PMID- 24599125 OWN - NLM STAT- MEDLINE DCOM- 20140706 LR - 20201222 IS - 1538-7445 (Electronic) IS - 0008-5472 (Linking) VI - 74 IP - 9 DP - 2014 May 1 TI - Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. PG - 2455-64 LID - 10.1158/0008-5472.CAN-13-3009 [doi] AB - Because of the early onset of local invasion and distant metastasis, pancreatic ductal adenocarcinoma (PDAC) is the most lethal human malignant tumor, with a 5-year survival rate of less than 5%. In this study, we investigated the role of fascin, a prometastasis actin-bundling protein, in PDAC progression, invasion, and the molecular mechanisms underlying fascin overexpression in PDAC. Our data showed that the expression levels of fascin were higher in cancer tissues than in normal tissues, and fascin overexpression correlated with the PDAC differentiation and prognosis. Fascin overexpression promoted PDAC cell migration and invasion by elevating matrix metalloproteinase-2 (MMP-2) expression. Fascin regulated MMP-2 expression through protein kinase C and extracellular signal-regulated kinase. Importantly, our data showed that hypoxia induced fascin overexpression in PDAC cells by promoting the binding of hypoxia-inducible factor-1 (HIF-1) to a hypoxia response element on the fascin promoter and transactivating fascin mRNA transcription. Intriguingly, HIF-1alpha expression levels in PDAC patient specimens significantly correlated with fascin expression. Moreover, immunohistochemistry staining of consecutive sections demonstrated colocalization between HIF-1alpha and fascin in PDAC specimens, suggesting that hypoxia and HIF-1alpha were responsible for fascin overexpression in PDAC. When ectopically expressed, fascin was able to rescue PDAC cell invasion after HIF-1alpha knockdown. Our results demonstrated that fascin is a direct target gene of HIF-1. Our data suggested that the hypoxic tumor microenvironment in PDAC might promote invasion and metastasis by inducing fascin overexpression, and fascin might be targeted to block PDAC progression. CI - (c)2014 AACR. FAU - Zhao, Xiao AU - Zhao X AD - Authors' Affiliations: Department of Pancreatic Carcinoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China; and Department of Tumor Biology and Comprehensive Melanoma Research Center, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. FAU - Gao, Song AU - Gao S FAU - Ren, He AU - Ren H FAU - Sun, Wei AU - Sun W FAU - Zhang, Huan AU - Zhang H FAU - Sun, Jianwei AU - Sun J FAU - Yang, Shengyu AU - Yang S FAU - Hao, Jihui AU - Hao J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140305 PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 0 (Carrier Proteins) RN - 0 (FSCN1 protein, human) RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Microfilament Proteins) RN - EC 3.4.24.24 (MMP2 protein, human) RN - EC 3.4.24.24 (Matrix Metalloproteinase 2) SB - IM MH - Aged MH - Binding Sites MH - Carcinoma, Pancreatic Ductal/*metabolism/mortality/secondary MH - Carrier Proteins/*genetics/metabolism MH - Cell Line, Tumor MH - Female MH - Gene Expression MH - Gene Expression Regulation, Neoplastic MH - HEK293 Cells MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/*physiology MH - Kaplan-Meier Estimate MH - Male MH - Matrix Metalloproteinase 2/genetics/metabolism MH - Microfilament Proteins/*genetics/metabolism MH - Middle Aged MH - Neoplasm Invasiveness MH - Pancreatic Neoplasms/*metabolism/mortality/pathology MH - Promoter Regions, Genetic MH - Response Elements MH - *Transcriptional Activation EDAT- 2014/03/07 06:00 MHDA- 2014/07/07 06:00 CRDT- 2014/03/07 06:00 PHST- 2014/03/07 06:00 [entrez] PHST- 2014/03/07 06:00 [pubmed] PHST- 2014/07/07 06:00 [medline] AID - 0008-5472.CAN-13-3009 [pii] AID - 10.1158/0008-5472.CAN-13-3009 [doi] PST - ppublish SO - Cancer Res. 2014 May 1;74(9):2455-64. doi: 10.1158/0008-5472.CAN-13-3009. Epub 2014 Mar 5.